OriBase Pharma is fully dedicated to the discovery & early development of novel & best-in-class targeted therapies (kinase inhibitors) from discovery to clinical validation for indications with high and unmet medical needs in oncology. Our mission is to deliver safe, drug-like novel molecular entities (NCEs and NBEs) ready for clinical trials through the application of a unique technology platform & efficient discovery processes. Our commitment is to accomplish this with the highest quality & speed.